IP Library Granted Patent US 10,729,762
Granted Patent B2
US 10,729,762 · App. 15/848,706 · Granted Aug 4, 2020

HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto

Inventors: Rama Rao Amara (Decatur, GA); June Scott (Atlanta, GA); Bernard Quigley (Atlanta, GA); Venkateswarlu Chamcha (Atlanta, GA)
Assignee: Emory University
A61K39/21A61K39/12A61K45/06C07K14/005C12N7/00A61K2039/523A61K2039/542A61K2039/545A61K2039/55516A61K2039/55544A61K2039/55561A61K2039/55594C12N2710/24143C12N2740/15022C12N2740/16034C12N2740/16234
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,729,762
App. No.
15/848,706
Granted
Aug 4, 2020
Kind
B2
Abstract

This disclosure relates to recombinant bacteria, e.g. L. lactis , expressing heterologous pili containing human immunodeficiency virus (HIV) antigens. In certain embodiments, the recombinant bacteria are administered in combination with other HIV antigens, nucleic acids encoding HIV antigens, recombinant virus encoding HIV antigens, anti-viral agents and/or adjuvants in an effective amount to elicit a mucosal immune response against HIV.

Claims (4)

1. A composition comprising a gram-positive bacterium comprising a recombinant nucleic acid encoding a polypeptide chimera having an HIV antigen and encoding heterologous proteins capable of forming pili on the bacterium, wherein bacterium expresses the HIV antigen on the tip of the pili, and wherein the polypeptide chimera comprises an amino acid sequence of SEQ ID NO: 2.

2. The composition of claim 1 , wherein the bacterium is L. lactis.

3. The composition of claim 1 , wherein the recombinant nucleic acid encoding HIV antigen is configured between N terminus amino acids of a Cpa protein of a group A Streptococcus and C terminus amino acids from the Cpa.

4. The composition of claim 3 wherein the HIV antigen is Gag p24.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 26, 2018
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045165/0986 →
Continuity (3)
Division 14422490
Provisional Application 61698200 · Sep 7, 2012
Related Publication 20180125967A1 · May 10, 2018